PARP inhibitor XMD16-5, Purity ≥98%

Cat. No.: X23-10-ZQ217

PARP inhibitor XMD16-5, Purity ≥98%

Synonym: 1345098-78-3; XMD16-5; 2-[4-(4-Hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; PARP inhibitor

  • CAS Number: 1345098-78-3
  • Compound CID: 57340666
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
XMD16-5, soluble in DMSO and ethanol and insoluble in water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks.
Molecular Weight
416.48
Molecular Formula
C23H24N6O2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 81 mg/mL (194.48 mM); Water: Insoluble; Ethanol: 5 mg/mL (12 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
XMD16-5 can be used to explore BMK1 inhibition and its effects on cancer cell proliferation.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.